| Followers | 1441 |
| Posts | 30358 |
| Boards Moderated | 32 |
| Alias Born | 12/10/2012 |
Wednesday, November 24, 2021 7:54:55 AM
$AADI: So messed up yesterday........... More Price-Target RAISES today
$AADI HC Wainwright & Co. analyst Robert Burns maintains Aadi Bioscience with a Buy and raises the price target from $47 to $49.
News yesterday was sooooooooo big.
I'm shocked it went down like it did.
Someone is just dying to pick them up now.
They are the first and only on the market to address this rare form of Sarcoma and it fell like this.
Utter Stupidity !!!!!!!!
GO $AADI
$AADI HC Wainwright & Co. analyst Robert Burns maintains Aadi Bioscience with a Buy and raises the price target from $47 to $49.
News yesterday was sooooooooo big.
I'm shocked it went down like it did.
Someone is just dying to pick them up now.
They are the first and only on the market to address this rare form of Sarcoma and it fell like this.
Utter Stupidity !!!!!!!!
GO $AADI
Recent WHWK News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:23:09 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:20:47 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:19:48 PM
- Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 • PR Newswire (US) • 04/19/2026 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 08:53:19 PM
- Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series • PR Newswire (US) • 04/16/2026 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/16/2026 12:03:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:34:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 10:46:06 PM
- Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026 • PR Newswire (US) • 04/10/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/10/2026 12:38:37 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/09/2026 11:54:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 12:32:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 10:21:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 10:20:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 10:18:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 10:17:15 PM
- Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 • PR Newswire (US) • 03/17/2026 08:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/12/2026 08:49:14 PM
- Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights • PR Newswire (US) • 03/12/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 11:36:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 11:35:11 PM
- Whitehawk Therapeutics to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/26/2026 01:00:00 PM
- Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • PR Newswire (US) • 02/18/2026 01:00:00 PM
- Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 • PR Newswire (US) • 01/08/2026 01:00:00 PM
